New Trends In Next Generation Sequencing
This research report provides insights on the global next
generation sequencing market. Next-generation sequencing (NGS), also known as
high-throughput sequencing. NGS enables rapid sequencing of the base pairs in
DNA or RNA samples. NGS is driving discovery and enabling the future of
personalized medicine, genetic diseases, and clinical diagnostics. However, in
this research study, the products of NGS have been classified into three broad
segments as consumables, services and platforms.
Advancement in the field of
molecular biology has equally enhanced the sequencing procedures. Many industry
players have come up with innovative NGS technology in last few years. For
instance, Pacific Biosciences with Sequel, and Oxford Nanopore with PromethION.
Additionally, three advances NSG systems that dominate the market includes
Roche GS FLX (454), Illumina HiSeq 2000 (Solexa) and AB SOLiD (Agencourt).
Further modification and
automation of this process continued to increase sequencing data and time
reduction. Thereby allowing researchers to reach major milestones in the Human
Genome Project. NGS makes sequence based gene expression analysis a “digital”
alternative to analog techniques. It also aids in quantifying RNA expression
with the breadth of a microarray and the resolution of qPCR. Advancement
in genome sequencing has made the sequencing easy and accurate. These
technological advancements are likely to grow the market in near future.
Comments
Post a Comment